Select Category:
Rheonix to Exhibit and Share Data at IAFP 2023 Annual Meeting - Food Industry Executive
July 14, 2023News
At the IAFP 2023 Annual Meeting in Toronto, Rheonix will showcase a case study reflecting real-world customer experience using the Listeria PatternAlert assay.
Read More »Rheonix to Discuss Eurofins Listeria PatternAlert Customer Case Study at IAFP - Perishable News
July 12, 2023News
The case study was developed in collaboration with Eurofins Microbiology Laboratories, a provider of Listeria PatternAlert testing.
Read More »Rheonix to Showcase Case Study Reflecting Real-World Customer Experience Using Listeria PatternAlert Assay - Quality Assurance & Food Safety Magazine
July 12, 2023News
The Listeria PatternAlert assay is a fully automated molecular test that alerts food producers to recurring Listeria contamination and aids rapid identification of Listeria harborage sites in their facilities.
Read More »Automated Test Developed for Detecting Diarrheal Pathogens in Berries - Fruit Growers News
June 28, 2023News
Rheonix Inc. collaborated with the U.S. Food and Drug Administration’s Center for Food Safety and Applied Nutrition in developing a test for the detection of C. cayetanensis in food and environmental samples.
Read More »Rheonix Inc. Develops Fully Automated Cyclospora cayetanensis Test in Collaboration With FDA Center for Food Safety and Applied Nutrition - Perishable News
June 28, 2023News
Rheonix Inc. announced that it has completed development of a fully automated test for the detection of Cyclospora cayetanensis in food and environmental samples.
Read More »Rheonix Develops Fully Automated Cyclospora Test in Collaboration with FDA - Food Safety Magazine
June 27, 2023News
Rheonix Inc. announced that it has completed development of a fully automated test for the detection of Cyclospora cayetanensis in food and environmental samples.
Read More »Rheonix COVID-19™ MDx Assay Receives Expanded FDA Emergency Use Authorization to Include Saliva Home Collection Kit
Sept. 19, 2022News
Rheonix Inc. announced today that the United States Food and Drug Administration (FDA) has issued an expanded Emergency Use Authorization (EUA) for the Rheonix COVID-19™ MDx Assay to include home collection using the Rheonix Laboratories COVID-19 PCR Test Saliva Home Collection Kit. Rheonix’s fully automated sample-to-answer COVID-19 assay received its initial EUA for use on a range of respiratory specimens on April 29, 2020. The EUA has subsequently been expanded to include use of saliva as a sample type and use by both moderate and high complexity laboratories.
Read More »How Cayuga Health System Nimbly Met COVID Testing Demands - Clinical Lab Products
March 1, 2022News
Ithaca N.Y.’s Cayuga Health System Laboratory reduced turnaround times for COVID-19 testing from two weeks to same-day and quickly scaled to meet testing surges, thanks to its partnership with Rheonix.
Read More »Rheonix Receives FDA Clearance for Fully Automated Encompass MDx® Workstation and Molecular Test for Detection of Sexually Transmitted Infections – Rheonix.com
Jan. 10, 2022News
Rheonix Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance of its automated Encompass MDx® Workstation, along with its STI TriPlex™ Assay and Male Urine Collection Kit for the detection of sexually transmitted infections (STI).
Read More »The Rheonix COVID-19 test will detect the new Omicron variant – Clinical Lab Products
Dec. 8, 2021News
Rheonix said its COVID-19 MDx Assay can detect the newly emerging Omicron variant of SARS-CoV-2, as well as other variants that are of public health concern.
Read More »Business Briefs – Tompkins Weekly
Dec. 8, 2021News
Rheonix Inc. recently announced that the Rheonix COVID-19™ MDx Assay will detect the newly emerging omicron variant of SARS-CoV-2.
Read More »Ithaca based Rheonix says its COVID-19 test will detect newly emerging Omicron variant – WAER News Radio
Dec. 6, 2021News
Ithaca-based Rheonix says that its COVID-19 MDx assay test will detect the newly emerging Omicron variant.
Read More »Ithaca company’s COVID-19 test able to detect Omicron variant – WHCU News Radio
Dec. 3, 2021News
Experts at Rheonix announced their COVID-19 Assay can identify if someone has Omicron or any other variant.
Read More »COVID-19 test makers confirm their assays spot Omicron variant – Medical Product Outsourcing
Dec. 1, 2021News
Firms specializing in diagnostic tests for COVID-19 are working quickly to confirm their tests are still effective. Rheonix announced its Rheonix COVID-19 MDx assay will detect the newly emerging variant.
Read More »Ithaca-based company says its COVID-19 test kit will detect new Omicron variant – WSYR-TV
Nov. 30, 2021News
Rheonix in Tompkins County says its COVID-19 detection technology will identify the new strain.
Read More »The Rheonix COVID-19TM MDx Assay Reliably Detects Omicron (B.1.1.529) and other SARS-CoV-2 Variants of Concern
Nov. 30, 2021News
Rheonix Inc. today announced that the Rheonix COVID-19TM MDx Assay will detect the newly emerging omicron variant of SARS-CoV-2, as well as other variants of public health concern.
Read More »Tompkins County: One million COVID tests, second best vaccination record in state – Ithaca Times
April 13, 2021News
At a recent Tompkins County Legislature meeting, Legislature Chairwoman Leslyn McBean-Clairborne recognized Rheonix for its work in creating machines to turn around test results in a matter of hours.
Read More »Health leaders share COVID vaccine updates – Tompkins Weekly
Jan. 27, 2021News
In an address to the county, Cayuga Health President and CEO Dr. Martin Stallone praised Ithaca-based Rheonix for its advancements in testing technology.
Read More »Claxton-Hepburn Medical Center receives Rheonix COVID testing machine – NNY360
Jan. 24, 2021News
Claxton-Hepburn Medical Center received a Rheonix Encompass MDx workstation — to test for COVID-19 — from St. Lawrence County.
Read More »Inspired by his education, Cornell alumnus creates fast COVID-19 test – Finger Lakes Times
Jan. 18, 2021News
Greg Galvin, the 2014 Cornell Entrepreneur of the Year, is founder and CEO of Rheonix, an Ithaca-based company that is ramping up production of a fully automated, same-day test for SARS-CoV-2, the virus that causes COVID-19.
Read More »The ins and outs of COVID testing and how a local company fits in – Ithaca Times
Dec. 24, 2020News
Rheonix is a local biotechnology company whose diagnostic instruments process the majority of COVID-19 tests at Cayuga Medical Center.
Read More »Ithaca-Based Rheonix gets extension on FDA Emergency Use Authorization for COVID-19 test equipment – WICZ-TV
Dec. 21, 2020News
Rheonix, who specialize in molecular testing, developed a COVID-19 test and equipment at the start of the pandemic.
Read More »UB and industry partners work together to fight COVID-19 – WKBW-TV
Dec. 16, 2020News
Rheonix produces fully automated testing devices used in part to detect infectious disease.
Read More »UB industry partners step up to fight COVID-19 – University at Buffalo
Dec. 15, 2020News
In less than three months after the pandemic struck the U.S., Rheonix produced a fully automated COVID-19 diagnostic test.
Read More »Rheonix COVID-19™ MDx Assay Receives Expanded FDA Emergency Use Authorization to Include Saliva as a Sample Type – Lab Manager
Dec. 11, 2020News
Rheonix announced that the FDA has issued an expanded EUA for the Rheonix COVID-19™ MDx Assay.
Read More »Rheonix COVID-19™ MDx Assay Receives Expanded FDA Emergency Use Authorization to Include Saliva as a Sample Type – Clinical Lab Manager
Dec. 11, 2020News
The ability to test saliva samples for the presence of SARS-CoV-2 simplifies the sample collection process and streamlines the testing workflow.
Read More »Rheonix COVID-19 MDx Assay receives authorization to include saliva for testing – Lansing Star
Dec. 11, 2020News
The ability to test saliva samples simplifies the sample collection process and streamlines the testing workflow
Read More »Ithaca company gets approval for COVID-19 saliva test – WBNG-TV
Dec. 9, 2020News
Ithaca area company Rheonix has received FDA approval for a saliva test for COVID-19, an alternative to the typical nose swab.
Read More »Rheonix assay receives expanded FDA EUA for saliva samples – Medical Laboratory Observer
Dec. 9, 2020News
The Rheonix COVID-19 MDx Assay is processed on the fully automated Rheonix Encompass MDx workstation.
Read More »Inspired by his education, alumnus creates fast COVID-19 test – Cornell Chronicle
Dec. 9, 2020News
Rheonix is ramping up production of a fully automated, same-day test for SARS-CoV-2, the virus that causes COVID-19.
Read More »Rheonix obtains expanded EUA from FDA for COVID-19 assay – Medical Device Network
Dec. 8, 2020News
Molecular diagnostics instrument and assay maker Rheonix has received an expanded EUA from the FDA for its SARS-CoV-2 assay.
Read More »FDA gives Rheonix COVID-19 testing procedure emergency-use authorization – CNY Business Journal
Dec. 8, 2020News
The FDA has issued an expanded EUA for the Rheonix COVID-19 MDx assay.
Read More »Rheonix COVID-19 MDx Assay receives expanded EUA to include saliva as a sample type – Clinical Lab Products
Dec. 7, 2020News
The FDA has issued an expanded emergency use authorization for the Rheonix COVID-19 MDx Assay, from Rheonix.
Read More »FDA Emergency Use Authorization for Rheonix SARS-CoV-2 Assay Expanded to Include Saliva Samples – 360Dx
Dec. 7, 2020News
The Rheonix COVID-19 MDx Assay is now authorized for use with saliva specimens collected without preservatives in a sterile tube in a healthcare setting.
Read More »FDA Emergency Use Authorization for Rheonix SARS-CoV-2 Assay Expanded to Include Saliva Samples – Genomeweb
Dec. 7, 2020News
Molecular diagnostics instrument and assay maker Rheonix has received an expanded Emergency Use Authorization from the US Food and Drug Administration for its SARS-CoV-2 assay.
Read More »Rheonix COVID-19™ MDx Assay Receives Expanded FDA Emergency Use Authorization to Include Saliva as a Sample Type - Rheonix.com
Dec. 7, 2020News
Rheonix Inc. announced today that the United States Food and Drug Administration (FDA) has issued an expanded Emergency Use Authorization (EUA) for the Rheonix COVID-19™ MDx Assay and now allows the use of saliva as an approved sample type.
Read More »St. Lawrence hospitals gear up for COVID fight – WWNY-TV
Dec. 4, 2020News
St. Lawrence Health System is gearing up for more COVID testing with Rheonix testing workstations.
Read More »St. Lawrence County to purchase two COVID-19 rapid testing machines – North Country Public Radio
Nov. 26, 2020News
The machines are manufactured in Ithaca and can process around 88 tests in a day.
Read More »Pair of COVID-19 testing machines that return same-day test results coming to St. Lawrence County – North Country Now
Nov. 25, 2020News
The St. Lawrence County Legislature's Finance Committee voted to buy two COVID-19 testing machines that could return same-day test results.
Read More »GREG GALVIN, M.S. ’82, PH.D. ’84, MBA ’93 | Alumnus Company Ramps Up Production of Rapid COVID-19 Test - Cornell Engineering Magazine
Fall 2020News
With 22,000 pounds of assembly line equipment sitting outside his company headquarters, Greg Galvin, M.S. ’82, Ph.D. ’84, MBA ’93, quips that he forgot to factor the global pandemic into his business plans for this year.
Read More »Adirondack Health to expand COVID-19 rapid testing through new lab – North Country Public Radio
Nov. 23, 2020News
Adirondack Health in Saranac Lake is trying to increase its high-speed testing capacity, both for its own patients and eventually the broader North Country.
Read More »Adirondack Medical Center test-processing lab will be COVID resource for entire north country – NNY360
Nov. 15, 2020News
A new high-speed COVID-19 test lab opened last month with a single machine capable of processing 80 tests per day with a result turnaround time of 24 hours.
Read More »Rapid Covid testing in North Country gets much-needed boost – The Sun Community New
November 9, 2020News
Adirondack Health and the Trudeau Institute have opened the first phase of a high-speed COVID-19 testing laboratory that could ultimately produce up to 1,000 high-quality Covid-19 tests a day, health officials said last week.
Read More »Copley offers same-day COVID testing – Stowe Reporter
Nov. 5, 2020News
With new machinery, the hospital will no longer have to ship out hundreds of nasal swab samples weekly, waiting days for results.
Read More »Adirondack Health, Trudeau Institute launch high-speed COVID-19 testing lab – Adirondack Almanack
Oct. 29, 2020News
The high-speed COVID-19 testing laboratory is the first of its kind in the North Country.
Read More »Copley Hospital provides COVID testing – Copley Hospital
Oct. 27, 2020News
Copley Hospital announced the acquisition of a Rheonix COVID PCR Testing Analyzer, making COVID testing possible at Copley.
Read More »Congressman Tours Rheonix in Village of Lansing – The Lansing Star
October 16, 2020News
Congressman Tom Reed met with officials from Rheonix, a local molecular testing company in the Village of Lansing, to tour two manufacturing sites and a testing lab
Read More »Rheonix of Ithaca sees dramatic demand for its rapid COVID-19 testing equipment – Local SYR
Sept. 29, 2020News
The demand for rapid results from COVID-19 tests has dramatically increased business for an Ithaca area company, Rheonix.
Read More »FDA Publishes First Batch of SARS-CoV-2 MDx Limit of Detection Comparison Results - GenomeWeb
Sept. 16, 2020News
The US Food and Drug Administration on Tuesday published the first results of a limit of detection comparison of Emergency Use Authorized molecular diagnostic tests for SARS-CoV-2.
Read More »FDA Performance Comparison Results – U.S. Food & Drug Administration
Sept. 15, 2020News
FDA has published a performance comparison of molecular COVID-19 tests, showing Rheonix among the most sensitive methods.
Read More »UHS Receives Grants to Purchase COVID-19 Testing Instruments - Press Connects
August 17, 2020News
UHS purchased three COVID-19 MDx Assay and Encompass MDx workstations from Ithaca-based molecular testing company Rheonix, Inc.
Read More »Let’s End the Wait for Coronavirus Test Results. Here’s How. – The New York Times
July 31, 2020News
New York State Governor Andrew M. Cuomo offers important lessons on shortening the turnaround times and building sustainable COVID-19 testing, highlighting NYS’s investment in local companies such as Rheonix.
Read More »Governor Cuomo Announces 12 New York Companies to Start Producing COVID-19 Related Equipment and Supplies to Support In-State Needs – NY State Governor’s Office
July 30, 2020News
Rheonix receives grant for three quarters of a million dollars from NYS to assist with manufacturing scale-up to meet COVID-19 testing demand from NY State customers.
Read More »Oswego County COVID-19 Fund Supports Purchase Of Additional Testing Capabilities At Oswego Health – Oswego County Today
July 6, 2020News
The Oswego County COVID-19 Fund recently awarded Oswego Health with a grant to purchase a Rheonix Encompass MDx workstation which will enable the health system to complete in-house COVID-19 diagnostic testing to further support the community.
Read More »Rheonix Adapts and Innovates to Aid COVID-19 Response in Eastern Finger Lakes – Locate Finger Lakes Business Journal
June 30, 2020News
The Rheonix system consists of two main components: one, a test that enables detection of the virus that causes COVID-19; and two, a Rheonix-made, fully-automated workstation, which processes the test.
Read More »In a Time of Crisis, Some Local Companies Find Opportunity – Ithaca Voice
June 12, 2020News
Prior to Rheonix, COVID testing results would take at least a few days to get back - time where a person could expose others or risk their health taking a turn for the worse.
Read More »Developing a SARS-CoV-2 Testing Machine [Audio] – Locally Sourced Science
June 9, 2020News
Rheonix’s Doug Olsen discusses the company’s COVID-19 MDx Assay and Encompass MDx workstation.
Read More »As Criteria Expands, Testing Proves More Crucial Than Ever – Tompkins Weekly
June 3, 2020News
Since the COVID-19 pandemic hit Tompkins County in March, testing has been an invaluable component of the county’s coronavirus strategy.
Read More »Access to Coronavirus Testing Can Depend on Who You Know – The Wall Street Journal
May 31, 2020News
Diagnostic-testing capacity is gradually increasing across the U.S., and companies and communities are starting to have the breadth to test beyond those who are most severely ill or symptomatic.
Read More »Cayuga Health seeks to bolster COVID-19 testing with city, county partnership – Ithaca Voice
May 22, 2020News
The Tompkins County Legislature approved the purchase of a piece of lab equipment from Ithaca-based Rheonix to help expand the county's testing capacity as the Southern Tier continues reopening.
Read More »Tompkins County Legislature Gives Thumbs Up for COVID-19 Medical Equipment – WHCU News Radio
May 21, 2020News
During this week’s Tompkins County Legislature meeting, a resolution was put forward giving the approval for the purchase of new COVID-19 testing equipment from Ithaca-based Rheonix.
Read More »Tompkins County Approves Purchase of New One-Day Testing Device for COVID-19 – Ithaca Times
May 20, 2020News
At this week's Tompkins County Legislature meeting, a resolution approving the purchase of new testing equipment from Rheonix was passed unanimously.
Read More »Binghamton, UHS Partner to Bring More Testing to the Tier - Spectrum News
May 8, 2020News
A partnership between the city of Binghamton and United Health Services brings same-day COVID-19 testing to the Southern Tier.
Read More »Broome County Executive Welcomes Binghamton’s COVID Testing Deal - WNBF News Radio
May 8, 2020News
Mayor Richard David announced the city of Binghamton has supplied an automated Rheonix Encompass MDx workstation to UHS for same-day testing.
Read More »Rheonix Receives EUA for COVID-19 Test [Audio] - WHCU Radio
May 6, 2020News
Rheonix’s Brooke Schwartz discusses the company’s COVID-19 testing method.
Read More »City of Binghamton, UHS and Ithaca-based life science company partner to increase COVID-19 testing - WIVT-TV
May 7, 2020News
The City of Binghamton is partnering with UHS and an Ithaca based life science company to provide additional coronavirus testing in the community.
Read More »Reopening NY: Binghamton, UHS, Ithaca company ramp up coronavirus testing - Press & Sun-Bulletin
May 7, 2020News
Binghamton's first-responders, essential personnel and others will be able to undergo same-day testing for COVID-19. The city is partnering with United Health Services and an Ithaca-based company, which will allow the area to ramp up testing.
Read More »Same-Day COVID-19 Testing Coming to Binghamton - WICZ-TV
May 7, 2020News
The City of Binghamton has used federal COVID-19 relief money to purchase a machine and testing kits that make it possible to get same-day results. The technology, made by an Ithaca-based company called Rheonix, was purchased by the city, for UHS.
Read More »Binghamton Announces It Can Test 200 People a Day with New Technology - WBNG-TV
May 7, 2020News
Binghamton Mayor Rich David announced a new partnership between the city, UHS and Rheonix Inc. of Ithaca.
Read More »Mayor David Announces Partnership With United Health Services For Same-Day Local COVID-19 Virus Testing Program
May 7, 2020News
Mayor Richard C. David on Thursday joined John Carrigg, President and CEO of United Health Services (UHS), and Gregory J. Galvin, Ph.D., President and CEO of Rheonix Inc., to announce a same-day COVID-19 virus testing partnership between the City of Binghamton and United Health Services.
Read More »How an Ithaca-Based Biotechnology Company Became a Game Changer in Same-Day COVID-19 Testing - Cornell Daily Sun
May 6, 2020News
The Food and Drug Administration gave Rheonix, housed in Cornell’s Business and Technology Park, approval for an automated testing system for SARS-CoV-2.
Read More »Rheonix Receives FDA EUA for Rapid, Fully Automated Molecular COVID-19 Test - Lab Manager
May 6, 2020News
Rheonix Inc. received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA) for the Rheonix COVID-19TM MDx Assay.
Read More »New York Company Releases Fully Automated Coronavirus Test - WNYT-TV
May 5, 2020News
A New York company has released a fully automated coronavirus test. Rheonix received emergency use authorization from the FDA.
Read More »Rheonix Receives FDA Emergency Use Authorization for Molecular COVID-19 Test - Medical Laboratory Observer
May 4, 2020News
Rheonix has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for a fully automated molecular test to detect SARS-CoV-2 directly from respiratory samples.
Read More »Ithaca Company Gets FDA Clearance for Rapid COVID-19 Test - WENY-TV
May 1, 2020News
An Ithaca based company just received emergency FDA clearance for a rapid COVID-19 test.
Read More »Rheonix of Ithaca Gets FDA Approval for Rapid, Fully Automated Molecular COVID-19 Test - WSYR-TV
May 1, 2020News
Rheonix has received Emergency Use Authorization from the Food and Drug Administration for its COVID-19 test.
Read More »Cayuga Health Teams Up with Ithaca-Based Rheonix to Provide Same-Day Turnaround For COVID-19 Testing - WIVT-TV
May 1, 2020News
Cayuga Health and Rheonix Inc. announced that they are now able to provide same day turnaround for COVID-19 test results.
Read More »Rheonix COVID-19 Test Gets FDA Ok - RT Magazine
May 1, 2020News
Rheonix Inc. has received emergency use authorization from the FDA for the Rheonix COVID-19 MDx Assay.
Read More »Rheonix Gets Emergency Clearance for COVID-19 Assay - LabPulse
April 30, 2020News
The U.S. Food and Drug Administration (FDA) has granted molecular testing company Rhoenix emergency use authorization for a fully automated test to detect the presence of the novel coronavirus from respiratory samples.
Read More »Same Day COVID-19 Testing Coming to Tompkins County - Spectrum News
April 30, 2020News
Cayuga Med is partnering with Rheonix, an Ithaca-based company that has FDA emergency use authorization for the rapid test kits.
Read More »Rheonix Gets FDA Emergency Use Authorization for Coronavirus MDx Test - GenomeWeb
April 30, 2020News
Rheonix has received Emergency Use Authorization from the US Food and Drug Administration for the Rheonix COVID-19 MDx assay.
Read More »Biotech Company Approved to Use New Coronavirus Test - WIVB-TV
April 30, 2020News
An Ithaca-based biotechnology company with an office in Grand Island has been approved to use a new coronavirus test.
Read More »Rheonix Gets Emergency Approval for New COVID-19 Test - WGRZ-TV
April 30, 2020News
Rheonix has received Emergency Use Authorization through the FDA for a new, fully-automated test used to detect COVID-19 that can yield same-day results.
Read More »Same-Day COVID-19 Testing Results Now Available in Tompkins County - Ithaca Times
April 30, 2020News
The test is designed to operate on the Rheonix Encompass MDx® workstation and will facilitate same-day results at distributed testing locations.
Read More »Coronavirus Testing Site in Ithaca to Provide Same-Day Test Results - Ithaca Journal
April 30, 2020News
With help from Ithaca-based Rheonix, Tompkins County residents who use Cayuga Health's COVID-19 sampling site can get same-day results.
Read More »Cayuga Health Teams Up with Rheonix for Rapid-Turnaround COVID-19 Testing - WHCU Radio
April 30, 2020News
Cayuga Health will be using Rheonix’s rapid-turnaround COVID-19 tests at its sampling facility.
Read More »Local Company Partners with Cayuga Health to Launch Same-Day COVID Testing - The Ithaca Voice
April 30, 2020News
Cayuga Health (CH) and Ithaca-based biotech company Rheonix Inc. are now able to provide same-day turnaround for COVID-19 test results.
Read More »Cayuga Health, Ithaca-Based Rheonix Team Up to Provide Same-Day Turnaround for COVID-19 Testing - Finger Lakes Daily News
April 30, 2020News
The test is designed to operate on the Rheonix Encompass MDx® workstation and will facilitate same-day results at distributed testing locations.
Read More »Cayuga Health Teams Up with Ithaca-Based Rheonix to Provide Same-Day Turnaround For COVID-19 Testing - Cayuga Medical Center
April 30, 2020News
Cayuga Health (CH) and Rheonix Inc. announced today that they are now able to provide same day turnaround for COVID-19 test results.
Read More »Rheonix Inc. Receives FDA Emergency Use Authorization for Rapid, Fully Automated Molecular COVID-19 Test - Rheonix.com
April 30, 2020News
Sample-to-answer method will enable rapid testing in distributed locations.
Read More »Ithaca company developing a new, quicker way to test patient samples for the coronavirus - Ithaca Times
April 2, 2020News
Rheonix is one of countless companies around the country that are trying to fill the gaps in testing created by the ravenous spread of the COVID-19 virus.
Read More »Ithaca-based Rheonix creates fast COVID-19 test - Tompkins Weekly
April 1, 2020News
Once cleared by the FDA, Rheonix’s new COVID-19 test could provide faster test results than what is currently available.
Read More »Rheonix, an Ithaca company making a quicker COVID-19 test - CNY Central
March 28, 2020News
With the need of COVID-19 testing kits growing, Rheonix has created a device to help speed up the testing time.
Read More »Ithaca Company Developing COVID-19 test kit [Audio] - NewsRadio 570 WSYR
March 25, 2020News
Rheonix’s Gregory Galvin, Ph.D., discusses the company’s COVID-19 testing method.
Read More »Rheonix Developing Fully Automated COVID-19 Test [Audio] - WHCU Radio
March 25, 2020News
Rheonix’s Brooke Schwartz discusses the company’s COVID-19 testing method.
Read More »Rheonix Works to Develop Faster COVID-19 Testing Machine - WENY-TV
March 24, 2020News
With all of the testing happening in New York and around the nation, labs and testing sites are back logged, meaning results are not ready for days. But Rheonix is hoping to change the timeline from days to hours.
Read More »Rheonix could speed up coronavirus test results - WSYR-TV
March 23, 2020News
Ithaca’s Rheonix is making a small tweak to the company’s system used in another industry. With it, COVID-19 tests can come back in hours and not days.
Read More »Commercial Coronavirus Test Developers Tweak Timelines, EUA Plans in Light of Loosened FDA Guidance - GenomeWeb
March 20, 2020News
Companies like Rheonix are preparing to ramp up production not only of the new SARS-CoV-2 assays but also of the designated testing systems in anticipation of increased demand.
Read More »Rheonix Inc. to Launch Rapid, Fully Automated Coronavirus Disease 2019 (COVID-19) Assay - Rheonix.com
March 19, 2020News
Assay to provide small and medium-sized labs access to fast, cost-effective, sample-to-answer testing for public health threat.
Read More »Rheonix Working on a Fully Automated Testing Solution to Detect the COVID-19 Virus - WRGB-TV
March 19, 2020News
Labs like Rheonix are just one of dozens of labs working on developing new testing solutions.
Read More »Western NY Science Experts Ask FDA to OK New Coronavirus Testing System - WGRZ-TV
March 17, 2020News
Rheonix Corporation, which has an office on Grand Island, NY, is now pushing for federal approval for its robotic testing equipment.
Read More »Rheonix Developing Fully Automated COVID-19 Test in Collaboration with Western New York Partners - Buffalo News
March 16, 2020 News
Rheonix is developing a test to simplify detection of SARS-CoV-2, the virus that causes COVID-19. The fully automated and self-contained testing solution, which Rheonix is developing in collaboration with Zeptometrix, the University at Buffalo, and Catholic Health Systems of Western New York, can be implemented by small and medium throughput labs once regulatory approval is obtained.
Read More »Automated Assay Maps Persistent Listeria - Food Technology Magazine (IFT)
October 1, 2019News
Rheonix and Mérieux NutriSciences announced in July 2019 the results of a case study designed to show how Rheonix’s Listeria PatternAlert Assay in combination with Mérieux’s EnviroMap visualization software can help food processors identify where Listeria may be persisting in their facilities and take prompt corrective action.
Read More »Rheonix Launches Automated DNA Extraction and Library Preparation Solution
December 20, 2018News
The method will enable laboratory technicians to produce sequence-ready libraries directly from raw samples, with significantly reduced hands-on time compared with current methods.
Read More »Foodborne Illness Outbreaks in Spotlight as Technology Improves
December 18, 2018News
Growing number of multistate outbreak investigations raise pressure on U.S. food companies, from farm to fork
Read More »Roundup of New Rapid Testing Tools Enhancing Food Safety
November 29, 2018News
Rheonix technology featured in Food Quality & Safety Magazine's online article on new rapid testing methods in food safety.
Read More »Zika Dx Development Process Could Provide Roadmap for Other Tests, Rheonix, Collaborators Say
March 2, 2018News
Researchers at Rheonix and the New York University College of Dentistry have developed a nucleic acid and antibody-based test for Zika virus.
Read More »NYU and Rheonix Collaborators Adapt HIV Test in Developing Rapid Diagnostic Test for Zika Virus
February 23, 2018News
Zika Test Uses Saliva to Detect Both Nucleic Acids and Antibodies of the Virus
Read More »Streamlining Library Preparation for Next-Generation Sequencing
October 5, 2016News
Clinical Lab Products article on Rheonix's exploration of methods to streamline DNA library preparation for next-generation sequencing.
Read More »“Dual Use” Assay Capabilities
October 5, 2016News
Clinical Lab Products article on Rheonix's development of a “dual use” assay.
Read More »Automating Molecular LDTs
October 5, 2016News
Rheonix's Richard Montanga discusses how advanced technologies can streamline assay workflows in research and clinical environments in Clinical Lab Products.
Read More »October 2016 Product Spotlight: Lab Automation
September 29, 2016News
Clinical Lab Products product spotlight on Rheonix's microfluidic molecular testing workstation, the Encompass Optimum.
Read More »Bringing Molecular Diagnostics to the Food and Beverage Industry in a very Economical Fashion
August 22, 2016News
Interview with Rheonix President & CEO Dr. Gregory Galvin by CEOCFO Magazine.
Read More »Rheonix Targets Perfect Pint With Beer Spoilage Detection Tech
August 19, 2016News
Rheonix has launched an assay for detecting beer spoilage on its recently unveiled platform for food and beverage testing.
Read More »Rheonix Sees Automation as Key to Expanding Molecular Testing
July 1, 2016News
Diagnostic Testing and Emerging Technologies recently spoke to Gregory Galvin, Ph.D., Rheonix’s CEO, as well as Richard Montagna, Ph.D., senior vice president of scientific and clinical affairs, regarding the company’s technology and its commercial launch.
Read More »
Rheonix® Headquarters
30 Brown Road, Suite 2
Ithaca, NY 14850 USA
For 24 Hour Customer Service and Technical Support
1-844-743-6649 (1-844-RHEONIX)
Main Office
1-607-257-1242
Rheonix Laboratories, a subsidiary of Rheonix, Inc., performs COVID-19 testing in Ithaca, NY. To schedule a test, please visit www.rheonixlabs.com. For up-to-date information on COVID-19, visit the CDC General webpage: https://www.cdc.gov/COVID19.
2024 copyright Rheonix, all rights reserved.
We use cookies to improve your website experience, analyze traffic, and remember preferences.